Early introductions and projections of the B.1.1.7 SARS-CoV-2 variant at the University of Texas at Austin
| dc.creator | Johnson, Kaitlyn | |
| dc.creator | Woody, Spencer | |
| dc.creator | Pasco, Remy | |
| dc.creator | Matsui, Cameron | |
| dc.creator | Lachmann, Michael | |
| dc.creator | Fox, Spencer J. | |
| dc.creator | Meyers, Lauren Ancel | |
| dc.date.accessioned | 2024-07-29T20:41:32Z | |
| dc.date.available | 2024-07-29T20:41:32Z | |
| dc.date.issued | 2021-02 | |
| dc.description.abstract | Recent identification of the highly transmissible novel SARS-CoV-2 variant in the UK (B.1.1.7) has raised concerns for renewed pandemic surges around the globe [1]. While this variant has only recently been identified in the United States, it has been predicted to become dominant as early as March of 2021 [2]. Starting in January of 2021, the University of Texas at Austin (UT) began sequencing positive SARS-CoV-2 specimens to accelerate the detection of novel variants. An estimated 390 to 1,000 University of Texas at Austin (UT) students arrived in Austin infected with SARS-CoV-2 at the start of the spring semester (January 2021) [3]. Some of these cases may have been infected with novel variants [4,5]. Given that UT recently confirmed its first cases of the B.1.1.7 variant among students, we conducted a rapid risk assessment to estimate the prevalence and future spread of the variant within the UT community. | |
| dc.description.department | Integrative Biology | |
| dc.identifier.uri | https://hdl.handle.net/2152/126240 | |
| dc.identifier.uri | https://doi.org/10.26153/tsw/52777 | |
| dc.subject | COVID-19 | |
| dc.subject | b.1.1.7 variant | |
| dc.subject | University of Texas at Austin | |
| dc.title | Early introductions and projections of the B.1.1.7 SARS-CoV-2 variant at the University of Texas at Austin | |
| dc.type | DataPaper |